Kurs & Likviditet
Kalender
2024-11-06 | Kvartalsrapport 2024-Q3 |
2024-08-22 | Kvartalsrapport 2024-Q2 |
2024-06-06 | Ordinarie utdelning AZT 0.00 NOK |
2024-06-05 | Årsstämma 2024 |
2024-05-08 | Kvartalsrapport 2024-Q1 |
2024-02-01 | Bokslutskommuniké 2023 |
2023-11-02 | Kvartalsrapport 2023-Q3 |
2023-08-17 | Kvartalsrapport 2023-Q2 |
2023-06-07 | Ordinarie utdelning AZT 0.00 NOK |
2023-06-06 | Årsstämma 2023 |
2023-05-04 | Kvartalsrapport 2023-Q1 |
2023-02-02 | Bokslutskommuniké 2022 |
2022-10-27 | Kvartalsrapport 2022-Q3 |
2022-08-18 | Kvartalsrapport 2022-Q2 |
2022-06-23 | Årsstämma 2022 |
2022-05-27 | Ordinarie utdelning AZT 0.00 NOK |
2022-04-28 | Kvartalsrapport 2022-Q1 |
2022-01-27 | Bokslutskommuniké 2021 |
2021-10-28 | Kvartalsrapport 2021-Q3 |
2021-08-19 | Kvartalsrapport 2021-Q2 |
2021-05-21 | Ordinarie utdelning AZT 0.00 NOK |
2021-05-20 | Årsstämma 2021 |
2021-04-22 | Kvartalsrapport 2021-Q1 |
2021-01-28 | Bokslutskommuniké 2020 |
2020-10-22 | Kvartalsrapport 2020-Q3 |
2020-08-19 | Kvartalsrapport 2020-Q2 |
2020-05-15 | Ordinarie utdelning AZT 0.00 NOK |
2020-05-14 | Årsstämma 2020 |
2020-04-23 | Kvartalsrapport 2020-Q1 |
2020-01-30 | Bokslutskommuniké 2019 |
2020-01-06 | Extra Bolagsstämma 2020 |
2019-10-24 | Kvartalsrapport 2019-Q3 |
2019-08-15 | Kvartalsrapport 2019-Q2 |
2019-05-16 | Ordinarie utdelning AZT 0.00 NOK |
2019-05-15 | Årsstämma 2019 |
2019-04-30 | Kvartalsrapport 2019-Q1 |
2019-01-30 | Bokslutskommuniké 2018 |
2018-10-18 | Kvartalsrapport 2018-Q3 |
2018-08-16 | Kvartalsrapport 2018-Q2 |
2018-05-09 | Ordinarie utdelning AZT 0.00 NOK |
2018-05-07 | Årsstämma 2018 |
2018-04-26 | Kvartalsrapport 2018-Q1 |
2018-02-01 | Bokslutskommuniké 2017 |
2017-10-19 | Kvartalsrapport 2017-Q3 |
2017-08-17 | Kvartalsrapport 2017-Q2 |
2017-05-12 | Ordinarie utdelning AZT 0.00 NOK |
2017-05-11 | Årsstämma 2017 |
2017-04-27 | Kvartalsrapport 2017-Q1 |
2017-02-02 | Bokslutskommuniké 2016 |
2016-10-26 | Kvartalsrapport 2016-Q3 |
2016-08-17 | Kvartalsrapport 2016-Q2 |
2016-05-12 | Ordinarie utdelning AZT 0.00 NOK |
2016-05-11 | Årsstämma 2016 |
2016-04-19 | Kvartalsrapport 2016-Q1 |
2016-02-11 | Bokslutskommuniké 2015 |
2016-02-11 | Kapitalmarknadsdag 2016 |
2015-11-03 | Kvartalsrapport 2015-Q3 |
2015-08-13 | Kvartalsrapport 2015-Q2 |
2015-05-13 | Ordinarie utdelning AZT 0.00 NOK |
2015-05-12 | Årsstämma 2015 |
2015-05-05 | Kvartalsrapport 2015-Q1 |
2015-02-17 | Bokslutskommuniké 2014 |
2014-11-05 | Kvartalsrapport 2014-Q3 |
2014-08-13 | Kvartalsrapport 2014-Q2 |
2014-05-15 | Ordinarie utdelning AZT 0.00 NOK |
2014-05-14 | Årsstämma 2014 |
2014-04-30 | Kvartalsrapport 2014-Q1 |
2014-02-14 | Bokslutskommuniké 2013 |
2013-11-01 | Kvartalsrapport 2013-Q3 |
2013-08-09 | Kvartalsrapport 2013-Q2 |
2013-06-13 | Kapitalmarknadsdag 2013 |
2013-05-28 | Ordinarie utdelning |
2013-05-27 | Årsstämma 2013 |
2013-05-07 | Kvartalsrapport 2013-Q1 |
2013-02-01 | Extra Bolagsstämma 2013 |
2013-01-07 | Bokslutskommuniké 2012 |
2012-11-06 | Kvartalsrapport 2012-Q3 |
2012-08-10 | Kvartalsrapport 2012-Q2 |
2012-05-07 | Ordinarie utdelning AZT 0.00 NOK |
2012-05-07 | Årsstämma 2012 |
2012-05-07 | Kvartalsrapport 2012-Q1 |
2012-02-21 | Bokslutskommuniké 2011 |
2011-11-08 | Kvartalsrapport 2011-Q3 |
2011-08-10 | Kvartalsrapport 2011-Q2 |
2011-05-13 | Kvartalsrapport 2011-Q1 |
2011-05-13 | Årsstämma 2011 |
2011-05-12 | Ordinarie utdelning |
2011-02-17 | Bokslutskommuniké 2010 |
2010-11-12 | Kvartalsrapport 2010-Q3 |
2010-08-10 | Kvartalsrapport 2010-Q2 |
2010-05-11 | Kvartalsrapport 2010-Q1 |
2010-05-04 | Årsstämma 2010 |
2010-03-03 | Bokslutskommuniké 2009 |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
Tromsø, Norway, 10[th] December 2021 - With reference to stock exchange announcement regarding option exercise published today, 10[th] December 2021, at 12.58 CET where CEO, Jethro Holter exercised 200,000 options at a strike price of NOK 8,00 per share, CEO Jethro Holter has sold 120.000 shares at NOK 88 per share to cover the tax obligation and the strike price following the exercise.
Following the transaction and registration of the shares, CEO Jethro Holter has 80.564 shares and 0 options in ArcticZymes Technoloiges ASA
The information included in this announcement is such that the Company is required to disclose in accordance with the EU Market Abuse Regulation (MAR) section and 19 and section 5-12 of the Norwegian Securities Trading Act.
The announcement is made by CFO Børge Sørvoll, 10 December 2021, at 1955 CET.
For more information, please contact:
ArcticZymes Technologies
CFO, Børge Sørvoll Tel: +47 95 29 01 87
ir@arcticzymes.com
About ArcticZymes Technologies ASA
ArcticZymes Technologies is a Norwegian life sciences company focused on the development, manufacturing and commercialization of novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and therapeutics.
Listed on the Oslo Stock Exchange since 2005 originally under the [Biotec] ticker, as Biotec Pharmacon. The company rebranded as ArcticZymes Technologies in 2020 under the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at the SIVA Innovation Centre.
ArcticZymes Technologies' IP and capabilities are protected via a large portfolio of patents.
For more information, please visit the website: www.arcticzymes.com.